Accredo
HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Cystadane® (betaine anhydrous) - overview

Cystadane® (betaine anhydrous)

Overview | Product information | Accredo services | Contact team


A rare metabolic condition, homocystinuria can be identified by an excess of homocysteine in the urine. This inherited disorder affects the metabolization of the amino acid methionine, a component found in food. The cause is usually attributed to a deficiency of cystathionine beta synthetase—an enzyme needed to properly digest methionine.

Homocystinuria is inherited as an autosomal recessive trait, which means a child must inherit the defective gene from both parents to be affected.

Referral form

Resources:

NORD - National Organization for Rare Diseases

Rare Disease Therapeutics


Cystadane is a registered trademark of Orphan Europe and is distributed in the United States by Rare Disease Therapeutics, Inc.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us